Caitlyn Guldenpfennig
Overview
Explore the profile of Caitlyn Guldenpfennig including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
132
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Thomas B, Guldenpfennig C, Daniels M, Burke D, Porciani D
Nucleic Acid Ther
. 2024 May;
34(3):109-124.
PMID: 38752363
Recent FDA approvals of mRNA vaccines, short-interfering RNAs, and antisense oligonucleotides highlight the success of oligonucleotides as therapeutics. Aptamers are excellent affinity reagents that can selectively label protein biomarkers, but...
2.
Thomas B, Guldenpfennig C, Guan Y, Winkler C, Beecher M, Beedy M, et al.
Mol Ther Nucleic Acids
. 2023 Oct;
34:102046.
PMID: 37869258
A significant fraction of non-small cell lung cancer (NSCLC) cases are due to oncogenic mutations in the tyrosine kinase domain of the epidermal growth factor receptor (EGFR). Anti-EGFR antibodies have...
3.
Guldenpfennig C, Teixeiro E, Daniels M
Front Immunol
. 2023 Aug;
14:1214095.
PMID: 37533858
NF-κB signaling is essential to an effective innate and adaptive immune response. Many immune-specific functional and developmental outcomes depend in large on NF-κB. The formidable task of sorting out the...
4.
Quaney M, Pritzl C, Luera D, Newth R, Knudson K, Saxena V, et al.
Proc Natl Acad Sci U S A
. 2023 Jan;
120(3):e2205049120.
PMID: 36634134
Stimulator of interferon genes (STING) signaling has been extensively studied in inflammatory diseases and cancer, while its role in T cell responses to infection is unclear. Using strains engineered to...
5.
Smyth D, Trujillo M, Gregory D, Cheung K, Gao A, Graham M, et al.
Nat Commun
. 2022 Mar;
13(1):1836.
PMID: 35354836
No abstract available.
6.
Smyth D, Trujillo M, Gregory D, Cheung K, Gao A, Graham M, et al.
Nat Commun
. 2022 Feb;
13(1):635.
PMID: 35115523
Tracking SARS-CoV-2 genetic diversity is strongly indicated because diversifying selection may lead to the emergence of novel variants resistant to naturally acquired or vaccine-induced immunity. To monitor New York City...